nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGA2B—respiratory system—chronic obstructive pulmonary disease	0.0449	0.362	CbGeAlD
Tirofiban—ITGB3—connective tissue—chronic obstructive pulmonary disease	0.0346	0.278	CbGeAlD
Tirofiban—Retroperitoneal haemorrhage—Formoterol—chronic obstructive pulmonary disease	0.0315	0.126	CcSEcCtD
Tirofiban—Retroperitoneal haemorrhage—Arformoterol—chronic obstructive pulmonary disease	0.0315	0.126	CcSEcCtD
Tirofiban—ITGA2B—Integrin alphaIIb beta3 signaling—RAPGEF3—chronic obstructive pulmonary disease	0.0294	0.0469	CbGpPWpGaD
Tirofiban—ITGA2B—lung—chronic obstructive pulmonary disease	0.0239	0.192	CbGeAlD
Tirofiban—ITGA2B—Platelet Aggregation (Plug Formation)—RAPGEF3—chronic obstructive pulmonary disease	0.0228	0.0364	CbGpPWpGaD
Tirofiban—ITGB3—Serotonin Transporter Activity—SLC6A4—chronic obstructive pulmonary disease	0.0226	0.0362	CbGpPWpGaD
Tirofiban—ITGB3—Integrin alphaIIb beta3 signaling—RAPGEF3—chronic obstructive pulmonary disease	0.0226	0.0361	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ELANE—chronic obstructive pulmonary disease	0.0223	0.0356	CbGpPWpGaD
Tirofiban—ITGB3—lung—chronic obstructive pulmonary disease	0.0209	0.168	CbGeAlD
Tirofiban—ITGB3—Platelet Aggregation (Plug Formation)—RAPGEF3—chronic obstructive pulmonary disease	0.0176	0.0281	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—ELN—chronic obstructive pulmonary disease	0.0162	0.0259	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP12—chronic obstructive pulmonary disease	0.0159	0.0254	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin Signaling—PLAU—chronic obstructive pulmonary disease	0.0115	0.0183	CbGpPWpGaD
Tirofiban—Haematemesis—Aminophylline—chronic obstructive pulmonary disease	0.0109	0.0435	CcSEcCtD
Tirofiban—ITGB3—Molecules associated with elastic fibres—TGFB2—chronic obstructive pulmonary disease	0.0103	0.0165	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—SLC6A4—chronic obstructive pulmonary disease	0.00964	0.0154	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—ADRB2—chronic obstructive pulmonary disease	0.00914	0.0146	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—TGFB2—chronic obstructive pulmonary disease	0.00827	0.0132	CbGpPWpGaD
Tirofiban—ITGB3—Serotonin Transporter Activity—IL1B—chronic obstructive pulmonary disease	0.00823	0.0132	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—PLAUR—chronic obstructive pulmonary disease	0.00815	0.013	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—TGFB2—chronic obstructive pulmonary disease	0.00806	0.0129	CbGpPWpGaD
Tirofiban—Hypercholesterolaemia—Tiotropium—chronic obstructive pulmonary disease	0.00754	0.0302	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.00707	0.0113	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—ADRB2—chronic obstructive pulmonary disease	0.00704	0.0112	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin Signaling—MMP9—chronic obstructive pulmonary disease	0.00679	0.0109	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.00674	0.0108	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—ELANE—chronic obstructive pulmonary disease	0.00665	0.0106	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAUR—chronic obstructive pulmonary disease	0.00639	0.0102	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—TGFB2—chronic obstructive pulmonary disease	0.00637	0.0102	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MMP12—chronic obstructive pulmonary disease	0.00635	0.0101	CbGpPWpGaD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—PLAUR—chronic obstructive pulmonary disease	0.00628	0.01	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.00613	0.00979	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.00584	0.00933	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—PLAU—chronic obstructive pulmonary disease	0.00572	0.00914	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—PLAU—chronic obstructive pulmonary disease	0.00571	0.00913	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00546	0.00872	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—SERPINA1—chronic obstructive pulmonary disease	0.00545	0.0087	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.00519	0.00829	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—ELANE—chronic obstructive pulmonary disease	0.00512	0.00818	CbGpPWpGaD
Tirofiban—ITGA2B—Signal transduction by L1—EGFR—chronic obstructive pulmonary disease	0.00485	0.00776	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—LEP—chronic obstructive pulmonary disease	0.00484	0.00773	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—ELN—chronic obstructive pulmonary disease	0.00474	0.00757	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP12—chronic obstructive pulmonary disease	0.00474	0.00757	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.00472	0.00754	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.0045	0.00719	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—chronic obstructive pulmonary disease	0.00449	0.00717	CbGpPWpGaD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—PLAU—chronic obstructive pulmonary disease	0.0044	0.00703	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00421	0.00672	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—PLAUR—chronic obstructive pulmonary disease	0.00415	0.00664	CbGpPWpGaD
Tirofiban—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00403	0.0161	CcSEcCtD
Tirofiban—ITGB3—Syndecan interactions—TGFB1—chronic obstructive pulmonary disease	0.00397	0.00634	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—IL10—chronic obstructive pulmonary disease	0.00394	0.00629	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL1B—chronic obstructive pulmonary disease	0.00381	0.00608	CbGpPWpGaD
Tirofiban—ITGB3—Signal transduction by L1—EGFR—chronic obstructive pulmonary disease	0.00374	0.00598	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—LEP—chronic obstructive pulmonary disease	0.00373	0.00596	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP12—chronic obstructive pulmonary disease	0.00365	0.00583	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—ELN—chronic obstructive pulmonary disease	0.00365	0.00583	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—SERPINE1—chronic obstructive pulmonary disease	0.00363	0.0058	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—IL1B—chronic obstructive pulmonary disease	0.0035	0.0056	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—chronic obstructive pulmonary disease	0.00347	0.00554	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—MMP9—chronic obstructive pulmonary disease	0.00339	0.00541	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	0.00323	0.00515	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00322	0.00514	CbGpPWpGaD
Tirofiban—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00321	0.0129	CcSEcCtD
Tirofiban—Myocardial infarction—Formoterol—chronic obstructive pulmonary disease	0.00315	0.0126	CcSEcCtD
Tirofiban—Myocardial infarction—Arformoterol—chronic obstructive pulmonary disease	0.00315	0.0126	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.00314	0.00501	CbGpPWpGaD
Tirofiban—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.00307	0.0123	CcSEcCtD
Tirofiban—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.00307	0.0123	CcSEcCtD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—VEGFA—chronic obstructive pulmonary disease	0.00304	0.00486	CbGpPWpGaD
Tirofiban—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00298	0.0119	CcSEcCtD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL1B—chronic obstructive pulmonary disease	0.00293	0.00468	CbGpPWpGaD
Tirofiban—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00291	0.0117	CcSEcCtD
Tirofiban—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.0029	0.0116	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP14—chronic obstructive pulmonary disease	0.00289	0.00462	CbGpPWpGaD
Tirofiban—ITGB3—Molecules associated with elastic fibres—TGFB1—chronic obstructive pulmonary disease	0.00287	0.00458	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—TLR4—chronic obstructive pulmonary disease	0.00281	0.0045	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00281	0.0045	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—SERPINE1—chronic obstructive pulmonary disease	0.0028	0.00447	CbGpPWpGaD
Tirofiban—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00274	0.011	CcSEcCtD
Tirofiban—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00273	0.0109	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00272	0.00434	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0027	0.0108	CcSEcCtD
Tirofiban—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00269	0.0108	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.00269	0.0043	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.00269	0.00429	CbGpPWpGaD
Tirofiban—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00267	0.0107	CcSEcCtD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—chronic obstructive pulmonary disease	0.00266	0.00425	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.00256	0.00409	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.00256	0.00409	CbGpPWpGaD
Tirofiban—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00254	0.0102	CcSEcCtD
Tirofiban—ITGB3—Monoamine Transport—TNF—chronic obstructive pulmonary disease	0.00254	0.00406	CbGpPWpGaD
Tirofiban—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00253	0.0101	CcSEcCtD
Tirofiban—ITGB3—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	0.00249	0.00397	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.00248	0.00396	CbGpPWpGaD
Tirofiban—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00245	0.0098	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.00242	0.00386	CbGpPWpGaD
Tirofiban—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0024	0.00962	CcSEcCtD
Tirofiban—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00239	0.00958	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.00236	0.00377	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—EGFR—chronic obstructive pulmonary disease	0.00235	0.00376	CbGpPWpGaD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—VEGFA—chronic obstructive pulmonary disease	0.00234	0.00374	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—MMP1—chronic obstructive pulmonary disease	0.0023	0.00368	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—TGFB1—chronic obstructive pulmonary disease	0.00229	0.00366	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—NOS3—chronic obstructive pulmonary disease	0.00225	0.0036	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—TGFB1—chronic obstructive pulmonary disease	0.00223	0.00357	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP14—chronic obstructive pulmonary disease	0.00223	0.00356	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—IL6—chronic obstructive pulmonary disease	0.00223	0.00356	CbGpPWpGaD
Tirofiban—ITGB3—Non-integrin membrane-ECM interactions—TGFB1—chronic obstructive pulmonary disease	0.00219	0.0035	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—chronic obstructive pulmonary disease	0.00219	0.0035	CbGpPWpGaD
Tirofiban—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00217	0.00869	CcSEcCtD
Tirofiban—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00217	0.00869	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.00217	0.00346	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—chronic obstructive pulmonary disease	0.00215	0.00343	CbGpPWpGaD
Tirofiban—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00214	0.00858	CcSEcCtD
Tirofiban—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00213	0.00853	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00209	0.00335	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	0.00207	0.00331	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—ALB—chronic obstructive pulmonary disease	0.00207	0.0033	CbGpPWpGaD
Tirofiban—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00822	CcSEcCtD
Tirofiban—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00822	CcSEcCtD
Tirofiban—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00822	CcSEcCtD
Tirofiban—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00822	CcSEcCtD
Tirofiban—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.00821	CcSEcCtD
Tirofiban—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00202	0.00809	CcSEcCtD
Tirofiban—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00805	CcSEcCtD
Tirofiban—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00805	CcSEcCtD
Tirofiban—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00199	0.00795	CcSEcCtD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	0.00197	0.00315	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—ALB—chronic obstructive pulmonary disease	0.00197	0.00315	CbGpPWpGaD
Tirofiban—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00197	0.00788	CcSEcCtD
Tirofiban—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00776	CcSEcCtD
Tirofiban—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00194	0.00776	CcSEcCtD
Tirofiban—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00187	0.0075	CcSEcCtD
Tirofiban—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.0075	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.00185	0.00296	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—MMP1—chronic obstructive pulmonary disease	0.00183	0.00292	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—TGFB2—chronic obstructive pulmonary disease	0.00182	0.0029	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—EGFR—chronic obstructive pulmonary disease	0.00181	0.00289	CbGpPWpGaD
Tirofiban—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00178	0.00714	CcSEcCtD
Tirofiban—ITGB3—ECM proteoglycans—TGFB1—chronic obstructive pulmonary disease	0.00177	0.00282	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.00176	0.00282	CbGpPWpGaD
Tirofiban—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00176	0.00703	CcSEcCtD
Tirofiban—Pain—Formoterol—chronic obstructive pulmonary disease	0.00176	0.00703	CcSEcCtD
Tirofiban—ITGB3—Integrins in angiogenesis—VEGFA—chronic obstructive pulmonary disease	0.00173	0.00276	CbGpPWpGaD
Tirofiban—Pain—Montelukast—chronic obstructive pulmonary disease	0.00172	0.00688	CcSEcCtD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—IL6—chronic obstructive pulmonary disease	0.00172	0.00274	CbGpPWpGaD
Tirofiban—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00171	0.00684	CcSEcCtD
Tirofiban—ITGA2B—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.0017	0.00271	CbGpPWpGaD
Tirofiban—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00169	0.00676	CcSEcCtD
Tirofiban—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00673	CcSEcCtD
Tirofiban—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00166	0.00663	CcSEcCtD
Tirofiban—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00163	0.00653	CcSEcCtD
Tirofiban—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00163	0.00653	CcSEcCtD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—chronic obstructive pulmonary disease	0.00162	0.00259	CbGpPWpGaD
Tirofiban—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.00649	CcSEcCtD
Tirofiban—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00162	0.00649	CcSEcCtD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.00162	0.00259	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00162	0.00258	CbGpPWpGaD
Tirofiban—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.00641	CcSEcCtD
Tirofiban—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.0016	0.00639	CcSEcCtD
Tirofiban—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.00638	CcSEcCtD
Tirofiban—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00159	0.00638	CcSEcCtD
Tirofiban—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00159	0.00636	CcSEcCtD
Tirofiban—ITGA2B—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00157	0.00252	CbGpPWpGaD
Tirofiban—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00157	0.00629	CcSEcCtD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—NOS3—chronic obstructive pulmonary disease	0.00157	0.00251	CbGpPWpGaD
Tirofiban—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00156	0.00626	CcSEcCtD
Tirofiban—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00154	0.00616	CcSEcCtD
Tirofiban—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00613	CcSEcCtD
Tirofiban—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00605	CcSEcCtD
Tirofiban—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00605	CcSEcCtD
Tirofiban—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.00605	CcSEcCtD
Tirofiban—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00593	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—NOS3—chronic obstructive pulmonary disease	0.00148	0.00236	CbGpPWpGaD
Tirofiban—ITGA2B—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.00144	0.0023	CbGpPWpGaD
Tirofiban—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00572	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	0.00143	0.00228	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—TGFB1—chronic obstructive pulmonary disease	0.00142	0.00227	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.0014	0.00224	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.00136	0.00218	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	0.00136	0.00217	CbGpPWpGaD
Tirofiban—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00543	CcSEcCtD
Tirofiban—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00543	CcSEcCtD
Tirofiban—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00532	CcSEcCtD
Tirofiban—ITGB3—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	0.00131	0.00209	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.00129	0.00206	CbGpPWpGaD
Tirofiban—Headache—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00515	CcSEcCtD
Tirofiban—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00515	CcSEcCtD
Tirofiban—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00513	CcSEcCtD
Tirofiban—Headache—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00504	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.00126	0.00201	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	0.00125	0.00199	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.00125	0.00199	CbGpPWpGaD
Tirofiban—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00497	CcSEcCtD
Tirofiban—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00488	CcSEcCtD
Tirofiban—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00488	CcSEcCtD
Tirofiban—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00486	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.00121	0.00194	CbGpPWpGaD
Tirofiban—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00478	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.00119	0.00191	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.00119	0.0019	CbGpPWpGaD
Tirofiban—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00118	0.00471	CcSEcCtD
Tirofiban—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00463	CcSEcCtD
Tirofiban—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00461	CcSEcCtD
Tirofiban—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00457	CcSEcCtD
Tirofiban—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00114	0.00455	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.00113	0.00181	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—VEGFA—chronic obstructive pulmonary disease	0.00113	0.0018	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00445	CcSEcCtD
Tirofiban—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00445	CcSEcCtD
Tirofiban—ITGB3—L1CAM interactions—EGFR—chronic obstructive pulmonary disease	0.00111	0.00177	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.00108	0.00173	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.0043	CcSEcCtD
Tirofiban—ITGB3—Signaling by VEGF—VEGFA—chronic obstructive pulmonary disease	0.00107	0.0017	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP1—chronic obstructive pulmonary disease	0.00105	0.00168	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.00104	0.00165	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000991	0.00158	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000968	0.00155	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000954	0.00152	CbGpPWpGaD
Tirofiban—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000951	0.0038	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—VEGFA—chronic obstructive pulmonary disease	0.000926	0.00148	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000919	0.00147	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000917	0.00147	CbGpPWpGaD
Tirofiban—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000883	0.00353	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	0.000876	0.0014	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000873	0.0014	CbGpPWpGaD
Tirofiban—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000855	0.00342	CcSEcCtD
Tirofiban—ITGA2B—Focal Adhesion—EGFR—chronic obstructive pulmonary disease	0.000834	0.00133	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000821	0.00131	CbGpPWpGaD
Tirofiban—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000819	0.00328	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.00081	0.00129	CbGpPWpGaD
Tirofiban—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000808	0.00323	CcSEcCtD
Tirofiban—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000808	0.00323	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000799	0.00128	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—SERPINE1—chronic obstructive pulmonary disease	0.000797	0.00127	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000795	0.00127	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000793	0.00127	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—IL6—chronic obstructive pulmonary disease	0.000781	0.00125	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000781	0.00313	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000753	0.0012	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—IL6—chronic obstructive pulmonary disease	0.000737	0.00118	CbGpPWpGaD
Tirofiban—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000735	0.00294	CcSEcCtD
Tirofiban—ITGB3—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000735	0.00117	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.00073	0.00117	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000723	0.00116	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—TP53—chronic obstructive pulmonary disease	0.000722	0.00115	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—VEGFA—chronic obstructive pulmonary disease	0.000714	0.00114	CbGpPWpGaD
Tirofiban—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000696	0.00279	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000673	0.00108	CbGpPWpGaD
Tirofiban—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00066	0.00264	CcSEcCtD
Tirofiban—ITGA2B—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000653	0.00104	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—EGFR—chronic obstructive pulmonary disease	0.000642	0.00103	CbGpPWpGaD
Tirofiban—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000642	0.00257	CcSEcCtD
Tirofiban—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000639	0.00256	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.000632	0.00101	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000624	0.000997	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000616	0.000983	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000615	0.000983	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000614	0.000981	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000613	0.000979	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—MMP9—chronic obstructive pulmonary disease	0.000611	0.000976	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000604	0.000966	CbGpPWpGaD
Tirofiban—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000595	0.00238	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000587	0.000938	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000583	0.000931	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.00058	0.000927	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000563	0.000899	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000557	0.00089	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000544	0.000869	CbGpPWpGaD
Tirofiban—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000534	0.00214	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—MMP9—chronic obstructive pulmonary disease	0.000518	0.000828	CbGpPWpGaD
Tirofiban—Headache—Prednisone—chronic obstructive pulmonary disease	0.000506	0.00203	CcSEcCtD
Tirofiban—ITGB3—Extracellular matrix organization—TGFB1—chronic obstructive pulmonary disease	0.000503	0.000804	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.00048	0.000767	CbGpPWpGaD
Tirofiban—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00048	0.00192	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.000474	0.000757	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—ALB—chronic obstructive pulmonary disease	0.000473	0.000756	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—VEGFA—chronic obstructive pulmonary disease	0.000466	0.000744	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000452	0.000723	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000449	0.000717	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000431	0.000689	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000426	0.000681	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000423	0.000676	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—EGFR—chronic obstructive pulmonary disease	0.000419	0.000669	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000418	0.000668	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000396	0.000633	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000396	0.000632	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000388	0.00062	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000388	0.00062	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—MMP9—chronic obstructive pulmonary disease	0.00037	0.000591	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.00037	0.000591	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000366	0.000584	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	0.000332	0.000531	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000328	0.000525	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000327	0.000522	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VEGFA—chronic obstructive pulmonary disease	0.000326	0.000521	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—IL6—chronic obstructive pulmonary disease	0.000322	0.000514	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TP53—chronic obstructive pulmonary disease	0.00032	0.000511	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000305	0.000488	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	0.000305	0.000487	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TGFB1—chronic obstructive pulmonary disease	0.000299	0.000478	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EGFR—chronic obstructive pulmonary disease	0.000299	0.000478	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—IL6—chronic obstructive pulmonary disease	0.000298	0.000477	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000297	0.000475	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000286	0.000457	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TNF—chronic obstructive pulmonary disease	0.000285	0.000455	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000282	0.00045	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000266	0.000425	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000252	0.000402	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—TP53—chronic obstructive pulmonary disease	0.000246	0.000393	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—IL6—chronic obstructive pulmonary disease	0.00023	0.000367	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000229	0.000366	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00022	0.000352	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000209	0.000333	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000205	0.000327	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000199	0.000318	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000177	0.000282	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000161	0.000257	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.00016	0.000255	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000153	0.000245	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000143	0.000229	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000136	0.000217	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000132	0.00021	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	0.000129	0.000206	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000123	0.000197	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.00011	0.000177	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—TP53—chronic obstructive pulmonary disease	0.000108	0.000173	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.000101	0.000162	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.94e-05	0.000159	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.92e-05	0.000158	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.35e-05	0.000133	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.64e-05	0.000122	CbGpPWpGaD
